Gregory E. Deavens Honored: Named Chairman of Hartford HealthCare Board

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Irrimax Receives FDA Clearance for Irrisept

"This new clearance from the FDA further solidifies Irrisept as the market leader in wound irrigation," said Mark Alvarez, CEO of Irrimax.

Gregory E. Deavens was named chairman of the Hartford HealthCare Board of Directors on June 16, 2020.

As executive vice president, chief financial officer, and treasurer of Independence Health Group, Gregory E. Deavens is responsible for all financial functions for Independence Health Group and its subsidiaries. He also plays a key role in strategic planning for the organization.

In nominating Deavens, Hartford HealthCare president and chief executive officer Jeffrey A. Flaks praised Deavens as a person of great integrity, a bright and committed leader who has made significant contributions to the financial stability of Hartford HealthCare during his seven years of service as a board member, including prior service as vice chair.

“I have always valued Greg’s expertise, passion and vision and I am excited to partner with him to continue Hartford HealthCare’s growth as the premiere healthcare system in our region,” Flaks said.

“Greg brings strong strategic planning and leadership skills to the role, as well as tremendous vision. He shares my passion for culture, for building a true system-of-care that is a model for the nation. Together, we are committed to building a more diverse and more equitable health system.”

Deavens succeeds David Hess, whose term as chairman ended. Hess will remain a member of the Board of Directors.

“I am honored to accept the very important role as chairman of the Hartford HealthCare Board and I am grateful to David Hess for his leadership and continued support,” Deavens said. “We have an ambitious path ahead of us, as together, we transform health care in Connecticut and beyond, with a clear focus on the Hartford HealthCare mission to improve the health and healing of the people and communities it serves. I am also encouraged by and share Hartford HealthCare’s commitment to eliminating health disparities in underserved communities.”

Before joining Independence Health Group in January 2017, Deavens was senior vice president and corporate controller at MassMutual Financial Group. Previously, he served as senior vice president and chief financial officer for MassMutual’s U.S. Insurance Group. His earlier experience includes financial leadership roles with New York Life Insurance Company, CIGNA, GE Capital, and PriceWaterhouse.

In addition to his leadership on the HHC board, Deavens serves on the board of directors for The Executive Leadership Council, the African American Museum in Philadelphia, and BCS Financial. He is also a member of the American Institute of Certified Public Accountants and the National Association of Corporate Directors.

Deavens holds a Bachelor of Science degree in Accounting from the Florida A&M University School of Business and Industry. He and his wife, Beverly, have three grown children.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.